ILYRATOSI Trademark

Trademark Overview

On Friday, December 17, 2021, a trademark application was filed for ILYRATOSI with the United States Patent and Trademark Office. The USPTO has given the ILYRATOSI trademark a serial number of 97178382. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, July 17, 2024. This trademark is owned by Biogen MA Inc.. The ILYRATOSI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for the treatment of arthritis; anti-interleukin-6 (il-6) receptor monoclonal antibody for the treatment of disease caused by il-6 production; pharmaceutical preparations for the treatment of cytokine release syndrome; pharmaceutical preparations for the treatment of systemic sclerosis-associated interstitial lung disease
ilyratosi

General Information

Serial Number97178382
Word MarkILYRATOSI
Filing DateFriday, December 17, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, July 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparation for the treatment of arthritis; anti-interleukin-6 (il-6) receptor monoclonal antibody for the treatment of disease caused by il-6 production; pharmaceutical preparations for the treatment of cytokine release syndrome; pharmaceutical preparations for the treatment of systemic sclerosis-associated interstitial lung disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOGEN INTERNATIONAL GMBH
Party Type21 - New Owner After Publication
Legal Entity Type27 - NOT AVAILABLE
AddressBAAR 6340
CH
Party NameBiogen MA Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameBiogen MA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, December 21, 2021NEW APPLICATION ENTERED
Wednesday, December 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 5, 2022ASSIGNED TO EXAMINER
Monday, January 10, 2022NON-FINAL ACTION WRITTEN
Monday, January 10, 2022NON-FINAL ACTION E-MAILED
Monday, January 10, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 14, 2022SUSPENSION LETTER WRITTEN
Monday, March 14, 2022LETTER OF SUSPENSION E-MAILED
Monday, March 14, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, May 18, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, May 24, 2022ASSIGNED TO LIE
Wednesday, May 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 25, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 7, 2023SOU EXTENSION 1 FILED
Tuesday, February 7, 2023SOU EXTENSION 1 GRANTED
Thursday, February 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 14, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 29, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 29, 2023SOU EXTENSION 3 FILED
Monday, August 14, 2023SOU EXTENSION 2 FILED
Monday, August 14, 2023SOU EXTENSION 2 GRANTED
Wednesday, August 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 29, 2023SOU EXTENSION 3 GRANTED
Thursday, November 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 30, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 17, 2024SOU EXTENSION 4 FILED
Wednesday, July 17, 2024SOU EXTENSION 4 GRANTED

Related Keywords

ilyratosi treatment pharmaceutical preparations disease release syndrome cytokine sclerosis lung interstitial